Short Interest in Sartorius (OTCMKTS:SARTF) Increases By 213.8%

Sartorius (OTCMKTS:SARTF) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totaling 2,451 shares, an increase of 213.8% from the June 15th total of 781 shares. Based on an average daily volume of 189 shares, the days-to-cover ratio is currently 13.0 days. Approximately 0.0% of the shares of the company are short sold.

Sartorius Price Performance

SARTF remained flat at $212.80 on Monday. The stock has a market capitalization of $7.28 billion, a P/E ratio of 98.98 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The business’s 50 day moving average is $211.18 and its 200 day moving average is $220.58. Sartorius has a 12-month low of $181.58 and a 12-month high of $227.00.

Sartorius Company Profile

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.